Navigation Links
Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation
Date:7/29/2008

t change the underlying course of the disease. It is widely hoped that the next generation of therapies will be disease modifying, that is, they will slow or stop the brain cell death and loss of function caused by Alzheimer's.

"We must develop better treatments for Alzheimer's that go beyond improving symptoms to drugs that actually change the course of the disease. Delaying the onset of Alzheimer's and slowing the progression of the disease means that millions of people would not get Alzheimer's, and that many who do get the disease might only experience mild symptoms. In addition, delaying the onset and slowing the progression of Alzheimer's in the next five years could generate billions of dollars annually in Medicare and Medicaid savings for nursing home care alone," Gandy said.

Dr. Gandy is Mount Sinai Professor of Alzheimer's Disease Research, Professor of Neurology and Psychiatry, and Associate Director of the Alzheimer's Disease Research Center at the Mount Sinai School of Medicine, New York City.

18-Month Phase III Trial Results for Tarenflurbil (Flurizan)

Myriad Genetics announced on June 30, 2008, that its Phase III trial of tarenflurbil (Flurizan) had failed to achieve statistical significance on either of its two primary endpoints, and that the company was abandoning development of the compound for Alzheimer's disease.

"While the results of the trial were certainly disappointing, just because the Flurizan Phase III clinical trial failed, doesn't mean that other amyloid-targeted therapies in the clinical trial pipeline aren't valid. We learn a great deal from every clinical study," Gandy said. "There are many ways to impact amyloid and its role in Alzheimer's. There are other drugs in development that target amyloid with mechanisms of action that are different from this one. One or more of these drugs may ultimately prove successful."

At ICAD 2008, detailed data and results from the trial were presented for the
'/>"/>

SOURCE Alzheimer's Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
2. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation
5. Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials
6. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
7. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
8. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
9. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
10. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
11. Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2015   , Boston Scientific to ... consideration of up to $1.65 billion, with $1.6 billion in ... alternatives for AMS, Women,s Health business , ... business Endo International plc (NASDAQ: ... into a definitive agreement with Boston Scientific (NYSE: ...
(Date:3/2/2015)...  BioMed Realty Trust, Inc. (NYSE: BMR ... feet of space in the most dynamic and valuable ... the termination of Vertex Pharmaceuticals, leases on three properties ... 28, 2015. BioMed Realty will receive a $14 million ... reposition the properties to meet the growing demand for ...
(Date:3/1/2015)... , March 1, 2015  An innovative interventional ... migraine sufferers sustained relief of their headaches, according ... of Interventional Radiology ,s Annual Scientific Meeting ... State University New York Empire State College in ... sphenopalatine ganglion (SPG) blocks to give patients enough ...
Breaking Medicine Technology:Endo Announces Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific 2Endo Announces Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific 3BioMed Realty Gets Back 313,000 Square Feet Of Valuable Real Estate In Cambridge Innovation District 2BioMed Realty Gets Back 313,000 Square Feet Of Valuable Real Estate In Cambridge Innovation District 3Image-guided treatment shown to break the migraine cycle 2Image-guided treatment shown to break the migraine cycle 3Image-guided treatment shown to break the migraine cycle 4
... of Proprietary siRNA Molecule in Acute ... ... Inc., a,development-stage pharmaceutical company focused on discovering and,developing novel RNA interference-based ... its proprietary product,candidate, AKIi-5, a siRNA compound discovered and developed by ...
... 16 AstraZeneca (NYSE:,AZN) today announced that the ... SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release,Tablets for maintenance treatment ... the FDA approved SEROQUEL XR for the acute ... experience high rates of symptom relapse, and as,a ...
Cached Medicine Technology:Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans 2Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans 3Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans 4SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia 2SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia 3SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia 4SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia 5SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia 6SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia 7SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia 8
(Date:3/2/2015)... 2015 Éminence Organic Skin Care, the ... excited to announce the launch of the Balance Collection, ... time-saving solution for those with combination skin. The Balancing ... divided jar to separate the products, consists of the ... Balancing Moisturizer Duo, also in a divided jar, contains ...
(Date:3/1/2015)... To help healthcare organizations ... practices compliantly and profitably, MDreferralPRO and Vericle ... The interoperability between a strategic referral management ... management system is necessary for a healthcare ... referral management and development solution relies on ...
(Date:3/1/2015)... Women’s Excellence is pleased to announce the addition of a ... There are over 75 terms and phrases available for viewing, with ... our patients a better understanding of what our Providers are talking ... With this resource, our patients are able to go back ... phrases that they may not remember or comprehend at the time ...
(Date:3/1/2015)... 01, 2015 Adults who are not ... for term or universal policies can now use the ... best life insurance companies for single adults can now ... http://quotespros.com/life-insurance.html . , The rate plans that nationwide ... tied to a number of life protection policies. The ...
(Date:3/1/2015)... 01, 2015 Ticket Down is a reputable ... at Soldier Field. Deadheads have been anxiously anticipating ... , Grateful Dead was formed 50 years ago back in ... as one until the untimely death of Jerry Garcia in ... genres including blues, reggae, rock, bluegrass, folk, space rock and ...
Breaking Medicine News(10 mins):Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 2Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 4Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Ticket Prices in Chicago at Soldier Field for 4th of July Weekend Celebration 2
... have found that Nepali rhesus is by all means ... currently been used in biomedical research. // The Nepali ... prevailing shortage of laboratory animals used for developing of ... of the current issue of the American Journal of ...
... introduction of a UN AIDS report, UN officials were prompted ... in Myanmar and Vietnam // , which is inadequate prevention ... was originally a HIV/AIDS haven, has shown remarkable decline in ... measures to combat AIDS go slack, there is a risk ...
... the warmth of summer, mosquitoes too are out to suck ... could mean a lethal injection of many harmful diseases//. ... that Delaware offers an ambient atmosphere for mosquito to breed. ... top 10 in the United States in human population density ...
... to 24-year-old adults in UK revealed that above half of them ... intoxicate, about 18 per cent of people from all ages in ... cent of people in UK, who were aged between 18-24 and ... – said doctors. ,In Scotland nearly 27 per cent ...
... have agreed to cooperate in sharing key intelligence inputs ... drugs trafficking and assist each other in disaster management. ... intelligence and information in these key security-related areas and ... of disaster management," a senior official told PTI Wednesday ...
... agitating medicos today on the future course of their anti-reservation// ... Court to resume duties immediately. ,A section of ... strike to honor the apex court direction, while others say ... was not addressed to medical students., ,Sources said heated ...
Cached Medicine News:Health News:Nepali Rhesus May be Used as an Alternate for HIV/AIDS Research 2Health News:Nepali Rhesus May be Used as an Alternate for HIV/AIDS Research 3
Phaco-emulsification systems CV series...
The unprecedented power, flexibility and versatility of the Series 20000 Legacy have made it the world's leading phacoemulsifier....
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....
Medicine Products: